Drug Platform Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana

/PRNewswire/ Q BioMed Inc. (OTCQB: QBIO) a biotech acceleration and commercial stage company focused on licensing and acquiring undervalued biomedical.

Denis corinKeith pinderPartnership or collaboration opportunitiesCompany reports revenue improvementSecurities exchangeCq biomed incSourceq biomed incDrug platform developmentPositive dataLiver cancerOrphan drug designationAbiomed incLooking statementsSecurities actSecurities exchange actBiomed media contact